Authrsors: Associated Press WASHINGTON (AP) — U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request J&J’s vaccine. U.S. authorities […]
Protection increases with increased usage of politically charged drug Authors: Art Moore WND News Center A large study on the impact of using ivermectin as a prophylaxis for COVID-19 found that regular users of the drug experienced up to a 92% reduction in mortality compared to those who did not. Brazilian research scientist Dr. Flavio […]
Authors: Jim Hoft September 7, 2022 Gateway Pundit The UK Health Security Agency banned the COVID vaccine from childrenwho had not turned five by the end of last month. The UK will no longer offer the vaccine to children aged 5 to 11. Wolf also discussed a recent investigation that revealed the devastating affects of the vaccine […]
Date: :August 23, 2022Source:RCSI Summary: New research from RCSI University of Medicine and Health Sciences has provided greater insight into the causes of Long COVID syndrome. The findings, which further investigate the link between Long COVID and blood clotting, have been published in the Journal of Thrombosis and Haemostasis. Long COVID syndrome is a broad collection […]
Infection with virus also associated with fivefold increase in risk of deep vein thrombosis, data suggests Authors: Linda Geddes The Guardian Catching Covid is associated with a fivefold increase in the risk of deep vein thrombosis (DVT) and a 33-fold increase in risk of a potentially fatal blood clot on the lung in the 30 […]
By Cristina Laila September 4, 2022 Embalmers are finding long, rubbery clots inside of corpses since the implementation of Covid vaccines. According to one Alabama embalmer who has been treating corpses for over 20 year, the strange fibrous clots emerged in May of 2021, shortly after the Covid vaccines first became available to the public. “It […]
Authors: Bart Jones August 27, 2022 Newsday Some medical experts on Long Island are disputing a new study that said Paxlovid did not help relieve COVID-19 symptoms in people under 65. Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalization and death for high-risk seniors, […]
Authors: Arielle Dreher Axios September 2, 2022 Paxlovid, once hailed as a “game-changer” for its ability to treat COVID-19 infections at home, is becoming one of the pandemic’s biggest enigmas. The intrigue: There’s growing concern about the link between Pfizer’s antiviral pill and COVID rebound, in which patients test positive or have symptoms days after a […]
Authors: Martina Patone, PhD; Xue W. Mei, PhD; Lahiru Handunnetthi, PhD; Sharon Dixon, MD; Francesco Zaccardi, PhD; Manu Shankar-Hari, PhD; Peter Watkinson, MD; Kamlesh Khunti, PhD; Anthony Harnden, PhD; Carol A.C. Coupland, PhD; Keith M. Channon, MD; Nicholas L. Mills, PhD; Aziz Sheikh, MD; Julia Hippisley-Cox, MD August 28, 2022 ORIGINAL RESEARCHARTICLECirculation. 2022;146:00–00. DOI: 10.1161/CIRCULATIONAHA.122.059970 […]
